Immunodeficiency
Primary immunodeficiencies (PIDs), also known as inborn errors of immunity (IEI) are a group of more than 400 potentially serious disorders that can lead to frequent or severe infections, swellings and autoimmune problems. PID/IEI discorders can be caused by defects in genes that control the immune system, and may be inherited.
Information for Patients and Carers
Common Variable Immunodeficiency (CVID) Updated October 2021
Immunoglobulin Replacement Therapy (IRT) Updated October 2021
Primary Immunodeficiency (Inborn Errors of Immunity) Updated October 2021
Severe Combined Immunodeficiency (SCID) Updated October 2021
Subcutaneous Immunoglobulin (SCIg) Therapy - General Information Updated August 2021
Subcutaneous Immunoglobulin (SCIg) Therapy - Equipment Checklist
Subcutaneous Immunoglobulin (SCIg) Therapy - Infusion Checklist
Information for Health Professionals
ASCIA Position Statement - Immunoglobulin Replacement Therapy (IRT) in Primary Immunodeficiency (PID) New September 2021
ASCIA Immunodeficiency Strategy for Australia and New Zealand
References - Hereditary Angioedema (HAE)
ASCIA Position Paper and Management Plan - Hereditary Angioedema (HAE)
References - Hereditary Angioedema (HAE)
ASCIA Clinical Update - Primary Immunodeficiencies (PID)
ASCIA Position Statement - Subcutaneous Immunoglobulin (SCIg)
ASCIA Guide – Setting up a Subcutaneous Immunoglobulin (SCIg) program in a hospital
ASCIA Guidelines - Standardised IVIg Infusion Rates for IRT
ASCIA Transfer Care Plan for patients on IRT (immunoglobulin replacement therapy)
ASCIA SCIg Competency Training Checklists
ASCIA Travel Plan for patients on SCIg (subcutaneous immunoglobulin) therapy
ASCIA ID Register How to access information (available to Members Only)
Content updated May 2022
